Serum samples were obtained after 10–12 h of fasting and were used for measurements of all biochemical parameters. Serum specimens were kept at −80°C until the tests were analyzed. Glucose, alanine transaminase (ALT), C-reactive protein (CRP), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglyceride levels were quantified using an Abbott Architect CI16200 device (New Jersey, USA) by spectrophotometric method. HOMA index was calculated by the formula: fasting glucose (mmol/L) × fasting insulin (μU/mL)/22.5. Insulin levels were analyzed by chemiluminescence method (Siemens, Advia centaur, 2006, Germany). Hemoglobin (Hb), hematocrit (Hct), and mean cell volume (MCV), which are complete blood parameters, were measured with an Abbott CELL-DYN 3700 device.
Cell dyn 3700 device
Manufactured by Abbott
The CELL-DYN 3700 is a compact, automated hematology analyzer designed for clinical laboratory use. It is capable of performing complete blood count (CBC) and three-part differential analysis on whole blood samples. The device utilizes optical and impedance-based technologies to obtain accurate measurements of red blood cells, white blood cells, and platelet counts.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using cell dyn 3700 device
1
Fasting Metabolic Biomarkers Analysis
2
Comprehensive Blood Profiling for Cardiovascular Risk
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Blood samples were taken from peripheral veins of patients who fasted overnight. Auto-analyzers were used to evaluate hematological results. Abbott Cell-Dyn 3700 device was used for total or differentiated leukocyte counts. Abbott Architect C16000 automated analyzer (Abbott Lab, Abbott Park, IL, USA) was used for total and specific high-density lipoprotein (HDL) cholesterol, triglycerides and fasting blood glucose levels. The Friedewald equation was used to calculate serum low-density lipoprotein (LDL) cholesterol concentrations. The participants in the patient group applied to the hospital in the early period after the onset of symptoms, and their laboratory parameters were checked on the day of the mps recording. The time between MPS and symptom onset was short. The laboratory parameters of the participants in the control group were checked at the time of application and cardiovascular stress test was performed on the same day.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!